232 related articles for article (PubMed ID: 28622945)
1. Safety of intracoronary provocative testing for the diagnosis of coronary artery spasm.
Ciliberti G; Seshasai SRK; Ambrosio G; Kaski JC
Int J Cardiol; 2017 Oct; 244():77-83. PubMed ID: 28622945
[TBL] [Abstract][Full Text] [Related]
2. Overview of complications during pharmacological spasm provocation tests.
Sueda S; Kohno H
J Cardiol; 2016 Jul; 68(1):1-6. PubMed ID: 27234219
[TBL] [Abstract][Full Text] [Related]
3. Induction of coronary artery spasm by two pharmacological agents: comparison between intracoronary injection of acetylcholine and ergonovine.
Sueda S; Kohno H; Fukuda H; Ochi N; Kawada H; Hayashi Y; Uraoka T
Coron Artery Dis; 2003 Sep; 14(6):451-7. PubMed ID: 12966266
[TBL] [Abstract][Full Text] [Related]
4. New combined spasm provocation test in patients with rest angina: intracoronary injection of acetylcholine after intracoronary administration of ergonovine.
Sueda S; Ochi T; Yano K; Mineoi K; Kondou T; Ochi N; Hayashi Y; Kukita H; Matsuda S; Kawada H; Tsuruoka T; Uraoka T
Jpn Circ J; 2000 Aug; 64(8):559-65. PubMed ID: 10952150
[TBL] [Abstract][Full Text] [Related]
5. Safety and optimal protocol of provocation test for diagnosis of multivessel coronary spasm.
Sueda S; Miyoshi T; Sasaki Y; Sakaue T; Habara H; Kohno H
Heart Vessels; 2016 Feb; 31(2):137-42. PubMed ID: 25366987
[TBL] [Abstract][Full Text] [Related]
6. Gender differences in sensitivity of acetylcholine and ergonovine to coronary spasm provocation test.
Sueda S; Miyoshi T; Sasaki Y; Sakaue T; Habara H; Kohno H
Heart Vessels; 2016 Mar; 31(3):322-9. PubMed ID: 25539623
[TBL] [Abstract][Full Text] [Related]
7. Clinical impact of selective spasm provocation tests: comparisons between acetylcholine and ergonovine in 1508 examinations.
Sueda S; Kohno H; Fukuda H; Ochi N; Kawada H; Hayashi Y; Uraoka T
Coron Artery Dis; 2004 Dec; 15(8):491-7. PubMed ID: 15585990
[TBL] [Abstract][Full Text] [Related]
8. Safety and potential usefulness of sequential intracoronary acetylcholine and ergonovine administration for spasm provocation testing.
Kinoshita Y; Saito Y; Kikuta Y; Sato K; Taniguchi M; Goto K; Takebayashi H; Haruta S; Kobayashi Y
Ther Adv Cardiovasc Dis; 2024; 18():17539447241233168. PubMed ID: 38396350
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcome according to spasm type of single coronary artery provoked by intracoronary ergonovine tests in patients without significant organic stenosis.
Kim DW; Her SH; Ahn Y; Shin DI; Han SH; Kim DS; Choi DJ; Kwon HM; Gwon HC; Jo SH; Rha SW; Baek SH
Int J Cardiol; 2018 Feb; 252():6-12. PubMed ID: 29249438
[TBL] [Abstract][Full Text] [Related]
10. Major complications during spasm provocation tests with an intracoronary injection of acetylcholine.
Sueda S; Saeki H; Otani T; Mineoi K; Kondou T; Yano K; Ochi T; Ochi N; Hayashi Y; Tsuruoka T; Kawada H; Matsuda S; Uraoka T
Am J Cardiol; 2000 Feb; 85(3):391-4, A10. PubMed ID: 11078314
[TBL] [Abstract][Full Text] [Related]
11. Transitional changes of acetylcholine spasm provocation test procedures.
Sueda S; Kohno H
Cardiovasc Interv Ther; 2020 Oct; 35(4):321-326. PubMed ID: 31641953
[TBL] [Abstract][Full Text] [Related]
12. Overview of the Acetylcholine Spasm Provocation Test.
Sueda S; Kohno H; Ochi T; Uraoka T
Clin Cardiol; 2015 Jul; 38(7):430-8. PubMed ID: 26175183
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological spasm provocation testing in 2500 patients: provoked spasm incidence, complications and cardiac events.
Sueda S
Heart Vessels; 2020 Oct; 35(10):1368-1377. PubMed ID: 32350639
[TBL] [Abstract][Full Text] [Related]
14. Differential incidence and morphology of provoked spasm between intracoronary acetylcholine and ergonovine testing: recommendation of supplementary use.
Sueda S; Fujimoto K; Sasaki Y; Sakaue T; Yoshii T; Habara H; Kohno H
Heart Vessels; 2019 May; 34(5):745-754. PubMed ID: 30474702
[TBL] [Abstract][Full Text] [Related]
15. Provocative tests for coronary artery spasm.
Cheng TO
Am J Cardiol; 1999 Aug; 84(4):497-8. PubMed ID: 10468103
[No Abstract] [Full Text] [Related]
16. Vasospastic Angina Diagnosed by the Spasm Provocation Test with the Combined Use of the Acetylcholine and Ergonovine Provocation Tests.
Matsumura M; Oshita C; Fujii Y; Ueda T; Teragawa H
Intern Med; 2019 Aug; 58(16):2377-2381. PubMed ID: 31118393
[TBL] [Abstract][Full Text] [Related]
17. Impact of pharmacological spasm provocation test in patients with a history of syncope.
Sueda S; Kohno H
Heart Vessels; 2018 Feb; 33(2):126-133. PubMed ID: 28905210
[TBL] [Abstract][Full Text] [Related]
18. Maximal acetylcholine dose of 200 μg into the left coronary artery as a spasm provocation test: comparison with 100 μg of acetylcholine.
Sueda S; Kohno H; Miyoshi T; Sakaue T; Sasaki Y; Habara H
Heart Vessels; 2015 Nov; 30(6):771-8. PubMed ID: 25179297
[TBL] [Abstract][Full Text] [Related]
19. The effect of intracoronary administration of ergonovine on the contralateral coronary artery in a provocation test for the diagnosis of variant angina.
Kim JH; Kim C; Kim J; Park JS; Lee HW; Choi JH; Lee HC; Cha KS; Hong TJ; Oh JH
Acta Cardiol; 2014 Dec; 69(6):628-34. PubMed ID: 25643433
[TBL] [Abstract][Full Text] [Related]
20. Intra-brachial ergonovine, not acetylcholine, is associated with radial artery vasospasm in patients with coronary vasospasm.
Wu YY; Mao WW; Li YF; Zhang Q; Zhang B; Sheng ZQ
Acta Cardiol; 2023 Feb; 78(1):135-141. PubMed ID: 35899777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]